Inter-individual differences in clopidogrel metabolism and platelet counts within platelet-rich plasma (PRP) intrigued us to optimize light transmittance aggregometry (LTA) assay in coronary artery disease (CAD) patients administered with clopidogrel and ticagrelor. The objective of the study was to optimize PRP preparation using separating gel PRP tubes to perform LTA among CAD patients on clopidogrel and ticagrelor.
No takes yet. Share an insight, caveat, or question.
Kashyap et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: